Nanocarry Therapeutics
Edit

Nanocarry Therapeutics

https://www.nanocarry.com/
Tags:BioTechDeliveryDevelopmentDrugPlatformProductResearch
Nanocarry is developing a new class of therapeutics based on bioengineered nanoparticles with novel capabilities to treat oncology indications and brain diseases. Using a proprietary “Plug and Play” approach, Nanocarry’s AxS platform can be easily modified to deliver a wide array of biologics, safely and effectively, to the brain and beyond. Nanocarry’s first products in development are for brain metastases of HER2+ breast cancer and non-small cell lung cancer.
Location: Israel
Member count: 1-10
Founded date: 2021

Investors 1

DateNameWebsite
18.09.2021NFXnfx.com